Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer (Q38445646)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 October 2004
edit
Language Label Description Also known as
English
Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer
scientific article published on 13 October 2004

    Statements

    Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer (English)
    Patricia M Lorusso
    David Waterhouse
    J Randolph Hecht
    Mary Varterasian
    Eric P Kaldjian
    David Y Mitchell
    Judith S Sebolt-Leopold

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit